The purpose of this study is to further describe the safety and tolerability of ORALAIR tablets in children 5 to 9 years of age with grass-pollen-induced allergic rhinitis with or without conjunctivitis.~Patients are followed for safety and tolerability during the first 30 treatment days.
Safety and tolerability of ORALAIR in children 5 to 9 years of age during the first 30 days of treatment.